臨床外科77巻13号

2022年12月発行

特集 新・外科感染症診療ハンドブック 総論

人工膵臓による感染性合併症予防

著者： 前田広道¹ 上村直¹ 宗景匡哉¹ 藤澤和音¹ 川西泰広¹ 田中智規¹ 山本奈緒² 壬生季代³ 花﨑和弘⁴

所属機関： ¹高知大学医学部外科 ²高知大学医学部附属病院医療技術部臨床工学部門 ³高知大学医学部附属病院看護部 ⁴高知大学医学部附属病院

ページ範囲：P.1419 - P.1424

【ポイント】
◆術後高血糖は感染性合併症の発生に関連しており，適切な周術期血糖管理の重要性が認識されてきている．
◆人工膵臓を用いた血糖管理（人工膵臓療法）の利点は，高い精度で目標血糖値を維持でき，従来法による血糖管理の大きな問題点である低血糖発作を回避できることである．
◆消化器外科領域における人工膵臓療法の至適目標血糖値は80〜120 mg/dL前後と考えられる．
◆人工膵臓療法は看護師の血糖管理業務に関連する労働負担を軽減する．

参考文献

1）Wang JY, Yang JH, Xu J, et al：Renal tubular damage may contribute more to acute hyperglycemia induced kidney injury in non-diabetic conscious rats. J Diabetes Complications 29：621-628, 2015

2）Wang J, Yue X, Meng C, et al：Acute Hyperglycemia May Induce Renal Tubular Injury Through Mitophagy Inhibition. Front Endocrinol（Lausanne）11：536213, 2020

3）Jafar N, Edriss H, Nugent K. The Effect of Short-Term Hyperglycemia on the Innate Immune System. Am J Med Sci 351：201-211, 2016

4）Chen JY, Nassereldine H, Cook SB, et al：Paradoxical Association of Hyperglycemia and Surgical Complications Among Patients With and Without Diabetes［published online ahead of print, 2022 Jun 15］. JAMA Surg ：e215561 2022

5）Kotagal M, Symons RG, Hirsch IB, et al：Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg 261：97-103, 2015

6）Pachot A, Cazalis MA, Venet F, et al：Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol 180：6421-6429, 2008

7）Marcuello M, Mayol X, Felipe-Fumero E, et al：Modulation of the colon cancer cell phenotype by pro-inflammatory macrophages：A preclinical model of surgery-associated inflammation and tumor recurrence. PLoS One 13：e0192958, 2018

8）Savioli F, Edwards J, McMillan D, et al：The effect of postoperative complications on survival and recurrence after surgery for breast cancer：A systematic review and meta-analysis. Crit Rev Oncol Hematol 155：103075, 2020

9）Chen G, Wang J, Chen K, et al：Relationship Between Postoperative Complications and the Prognosis of Gastric Carcinoma Patients Who Underwent Surgical Resection：A Systematic Review and Meta-Analysis. Cancer Control 28：10732748211011955, 2021

10）Hellinger WC, Crook JE, Heckman MG, et al：Surgical site infection after liver transplantation：risk factors and association with graft loss or death. Transplantation 87：1387-1393, 2009

11）Munekage M, Yatabe T, Sakaguchi M, et al：Comparison of subcutaneous and intravenous continuous glucose monitoring accuracy in an operating room and an intensive care unit. J Artif Organs 19：159-166, 2016

12）Fujii T, Hirai T, Suzuki S, et al：Surgical Site Infections and Inflammatory Reaction After Cardiac Surgery；Bedside Artificial Pancreas Versus Conventional Insulin Therapy：A Propensity Score-Matched Analysis. J Cardiothorac Vasc Anesth 36：840-846, 2022

13）Hanazaki K, Kitagawa H, Yatabe T, et al：Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system：the effects of no hypoglycemia. Am J Surg 207：935-941, 2014

14）Egi M, Bellomo R, Stachowski E, et al：Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 85：217-224, 2010

15）Mibu K, Yatabe T, Hanazaki K. Blood glucose control using an artificial pancreas reduces the workload of ICU nurses. J Artif Organs 15：71-76, 2012

16）Urai S, Hashimoto N, Takabe M, et al：Dynamic changes in insulin requirements with post-operative time using bedside artificial pancreas to maintain normoglycemia without hypoglycemia after cardiac surgery. J Artif Organs 25：72-81, 2022